Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: Part 1. Baseline and 3‐month observations
暂无分享,去创建一个
Oliver Pogarell | Wolfgang H Oertel | W. Oertel | J. Patterson | D. Hadley | O. Pogarell | H. Benamer | D. Grosset | H. Höffken | Donald M Hadley | Donald G Grosset | Jim Patterson | Hani T S Benamer | H Höffken | A Gerstner | A. Gerstner | J. Patterson
[1] Zadik Fr. ALCOHOL AND THE LIVER. , 1964, Lancet.
[2] B. Djahanguiri,et al. The prevention of acute gastric ulcer in the rat by alpha-methyldopa. , 1967, Medicina et pharmacologia experimentalis. International journal of experimental medicine.
[3] M. Hoehn,et al. Parkinsonism , 1967, Neurology.
[4] S. Fahn. Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale , 1987 .
[5] M. Critchley. Remembering Kinnier Wilson. , 1988, Movement disorders : official journal of the Movement Disorder Society.
[6] J. Talairach,et al. Co-Planar Stereotaxic Atlas of the Human Brain: 3-Dimensional Proportional System: An Approach to Cerebral Imaging , 1988 .
[7] W. Poewe,et al. APOMORPHINE TEST FOR DOPAMINERGIC RESPONSIVENESS , 1989, The Lancet.
[8] C D Marsden,et al. Differing patterns of striatal 18F‐dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy , 1990, Annals of neurology.
[9] A. Lees,et al. Challenge tests to predict the dopaminergic response in untreated Parkinson's disease , 1991, Neurology.
[10] M. Kaufman,et al. Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's‐diseased striatum , 1991, Synapse.
[11] A. Lees,et al. Ageing and Parkinson's disease: substantia nigra regional selectivity. , 1991, Brain : a journal of neurology.
[12] P. Seeman,et al. The Dopamine Transporter Is Absent in Parkinsonian Putamen and Reduced in the Caudate Nucleus , 1991, Journal of neurochemistry.
[13] A. Lees,et al. What features improve the accuracy of clinical diagnosis in Parkinson's disease , 1992, Neurology.
[14] P. Thompson,et al. Isolated tremor and disruption of the nigrostriatal dopaminergic system , 1992, Neurology.
[15] W. Oertel,et al. Apomorphine test for dopaminergic responsiveness in patients with previously untreated Parkinson's disease. , 1992, Archives of neurology.
[16] W. Koller,et al. When does Parkinson's disease begin? , 1992, Neurology.
[17] M Richards,et al. Subtle extrapyramidal signs can predict the development of dementia in elderly individuals , 1993, Neurology.
[18] M Schulzer,et al. Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism , 1994, Annals of neurology.
[19] D. Maraganore,et al. Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria. , 1995, Journal of neurology, neurosurgery, and psychiatry.
[20] L A Beckett,et al. Prevalence of parkinsonian signs and associated mortality in a community population of older people. , 1996, The New England journal of medicine.
[21] T. Ishikawa,et al. Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[22] D J Brooks,et al. An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease. , 1996, Brain : a journal of neurology.
[23] N. Quinn,et al. Multiple system atrophy: A review of 203 pathologically proven cases , 1997, Movement disorders : official journal of the Movement Disorder Society.
[24] J D Speelman,et al. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease. , 1997, Journal of neurology, neurosurgery, and psychiatry.
[25] J S Rakshi,et al. Measuring the rate of progression and estimating the preclinical period of Parkinson’s disease with [18F]dopa PET , 1998, Journal of neurology, neurosurgery, and psychiatry.
[26] W. Oertel,et al. 123I‐IBZM binding compared with long‐term clinical follow up in patients with de novo parkinsonism , 1998, Movement disorders : official journal of the Movement Disorder Society.
[27] Jan Booij,et al. Iodine-123-N-ω-Fluoropropyl-2β-Carbomethoxy-3β-(4-Iodophenyl)Tropane SPECT in Healthy Controls and Early-Stage, Drug-Naive Parkinson's Disease , 1998 .
[28] M. Brin,et al. Consensus Statement of the Movement Disorder Society on Tremor , 2008, Movement disorders : official journal of the Movement Disorder Society.
[29] C Trenkwalder,et al. The combination of hypointense and hyperintense signal changes on T2-weighted magnetic resonance imaging sequences: a specific marker of multiple system atrophy? , 1999, Archives of neurology.
[30] P. Hobson,et al. Accuracy of diagnosis in patients with presumed Parkinson's disease. , 1999, Age and ageing.
[31] S. Gacinovic,et al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]‐FP‐CIT SPECT imaging: The [123I]‐FP‐CIT study group , 2000, Movement disorders : official journal of the Movement Disorder Society.
[32] A. Bonnet. [The Unified Parkinson's Disease Rating Scale]. , 2000, Revue neurologique.
[33] D J Wyper,et al. Correlation of Parkinson's disease severity and duration with 123I‐FP‐CIT SPECT striatal uptake , 2000, Movement disorders : official journal of the Movement Disorder Society.
[34] Jan Booij,et al. The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism , 2001, European Journal of Nuclear Medicine.
[35] L Solymosi,et al. Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy. , 2001, Archives of neurology.
[36] Andrew J. Lees,et al. Improved accuracy of clinical diagnosis of Lewy body Parkinson’s disease , 2001, Neurology.
[37] D. Brooks,et al. Updated guidelines for the management of Parkinson's disease. , 2001, Hospital medicine.
[38] A J Lees,et al. What features improve the accuracy of clinical diagnosis in Parkinson's disease: A clinicopathologic study , 2001, Neurology.